formyl peptide receptor antagonists (Nikan Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameformyl peptide receptor antagonists (Nikan Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFormyl peptide receptors inhibitors
TargetsFormyl peptide receptors
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNikan Pharmaceuticals, LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNikan Pharmaceuticals, LLC
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A